XNCR
Xencor Inc
NASDAQ · Healthcare · Biotechnology · US
$23.19
+1.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.43x
- Price / sales
- 16.43x
- Price / cash flow
- -8.38x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 12.70x
- EV / EBITDA
- -10.78x
- EV / EBIT
- -6.17x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026